Odd ratio for development of new late symptoms after polio among Norwegian compared with Estonian patients
| New muscular weakness | New muscular pain | Fatigue | |||||||
|---|---|---|---|---|---|---|---|---|---|
| N (%) | OR (95% CI)* | p | N (%) | OR (95% CI)* | p | N (%) | OR (95% CI)* | p | |
| *Results adjusted for age, gender, type of findings (transitory findings or persistent paresis) and for reported additional neurological, rheumatological, cardiovascular and respiratory diseases. An interaction between type of findings and patient groups (Estonian-Norwegian) is included to the adjusted multiple regression analysis. | |||||||||
| Total | |||||||||
| Estonian | 67 (52.3) | 1.00 | 44 (34.4) | 1.00 | 66 (51.6) | 1.00 | |||
| Norwegian | 85 (59.9) | 1.13 (0.66 to 1.93) | 0.65 | 69 (48.9) | 1.89 (1.14 to 3.14) | 0.01 | 66 (45.5) | 0.70 (0.41 to 1.17) | 0.17 |
| Transitory findings | |||||||||
| Estonian | 38 (45.2) | 1.00 | 27 (32.1) | 1.00 | 38 (45.2) | 1.00 | |||
| Norwegian | 24 (41.4) | 0.90 (0.44 to 1.82) | 0.77 | 21 (35.6) | 1.22 (0.59 to 1.49) | 0.22 | 24 (38.7) | 0.65 (0.32 to 1.32) | 0.24 |
| Persistent paresis | |||||||||
| Estonian | 29 (65.9) | 1.00 | 17 (38.6) | 1.00 | 28 (63.6) | 1.00 | |||
| Norwegian | 61 (72.6) | 1.54 (0.68 to 3.46) | 0.3 | 48 (58.5) | 2.34 (1.09 to 5.03) | 0.03 | 45 (54.2) | 0.74 (0.34 to 1.63) | 0.46 |